Analysts See $-0.33 EPS for Summit Therapeutics plc (SMMT); Moore Capital Management LP Trimmed By $11.78 Million Its Advance Auto Parts (AAP) Position

Summit Therapeutics plc (NASDAQ:SMMT) Logo

Analysts expect Summit Therapeutics plc (NASDAQ:SMMT) to report $-0.33 EPS on June, 4.They anticipate $0.22 EPS change or 40.00% from last quarter’s $-0.55 EPS. After having $-0.35 EPS previously, Summit Therapeutics plc’s analysts see -5.71% EPS growth. The stock decreased 2.89% or $0.05 during the last trading session, reaching $1.68. About 4,029 shares traded. Summit Therapeutics plc (NASDAQ:SMMT) has declined 82.07% since May 19, 2018 and is downtrending. It has underperformed by 86.44% the S&P500. Some Historical SMMT News: 03/05/2018 - Summit Therapeutics at Non-Deal Roadshow Hosted By JMP Today; 19/04/2018 - SUMMIT COMPLETES DOSING OF EZUTROMID IN PHASEOUT DMD CLINICAL; 14/03/2018 - REG-Summit Highlights Scientific Rigour of its PhaseOut DMD Clinical Trial at MDA Clinical Conference; 20/04/2018 - REG-Summit Presents New 24-Week Analyses from PhaseOut DMD at the 2018 AAN Conference; 28/03/2018 - Summit Therapeutics Selected for Emerging Science Presentation at the 2018 American Academy of Neurology Annual Meeting; 19/04/2018 - SUMMIT COMPLETES DOSING OF EZUTROMID IN PHASEOUT DMD TRIAL; 07/03/2018 - REG-Summit Expands Enrolment in Phase 2 Clinical Trial to Include Planned Additional Group; 31/05/2018 - Summit Therapeutics Access Event Set By SunTrust for Jun. 7; 28/03/2018 - REG-Summit Therapeutics Selected for Emerging Science Presentation at the 2018 AAN Annual Meeting; 19/04/2018 - Summit Completes Dosing of Ezutromid in PhaseOut DMD Clinical Trial

Moore Capital Management Lp decreased Advance Auto Parts Inc (AAP) stake by 60% reported in 2018Q4 SEC filing. Moore Capital Management Lp sold 75,000 shares as Advance Auto Parts Inc (AAP)’s stock declined 11.48%. The Moore Capital Management Lp holds 50,000 shares with $7.87M value, down from 125,000 last quarter. Advance Auto Parts Inc now has $11.33B valuation. The stock increased 0.44% or $0.69 during the last trading session, reaching $157.97. About 1.13M shares traded or 2.34% up from the average. Advance Auto Parts, Inc. (NYSE:AAP) has risen 34.80% since May 19, 2018 and is uptrending. It has outperformed by 30.43% the S&P500. Some Historical AAP News: 02/04/2018 - ADVANCE AUTO PARTS INC - JEFF SHEPHERD WILL SERVE AS INTERIM CFO; 18/04/2018 - ADVANCE AUTO PARTS CEO GRECO 2017 TOTAL COMPENSATION $6.13M; 02/04/2018 - W W GRAINGER - MOST RECENTLY, OKRAY SERVED AS EVP AND CFO FOR ADVANCE AUTO PARTS; 22/05/2018 - ADVANCE AUTO PARTS SAYS EFFECTIVE MAY 16, BOARD ABOLISHED STANDING FINANCE COMMITTEE - SEC FILING; 02/04/2018 - Advance Auto Parts Reaffirms Full-Year Guidance; 22/05/2018 - Advance Auto Parts 1Q Adj EPS $2.10; 29/03/2018 - AAP IMPLANTATE AG AAQG.DE - AIMS TO START HUMAN CLINICAL STUDY IN COURSE OF CURRENT FINANCIAL YEAR; 22/05/2018 - Advance Auto Parts 1Q EPS $1.84; 21/04/2018 - DJ Advance Auto Parts Inc, Inst Holders, 1Q 2018 (AAP); 22/05/2018 - Advance Auto Parts Profit Rises

More notable recent Summit Therapeutics plc (NASDAQ:SMMT) news were published by: Nasdaq.com which released: “UK new car registrations fall 4.1 pct in April - SMMT - Nasdaq” on May 07, 2019, also Globenewswire.com with their article: “Exercise of Restricted Stock Units London Stock Exchange:SUMM - GlobeNewswire” published on April 24, 2019, Seekingalpha.com published: “Summit Therapeutics Has Started Attracting Institutional Investors Again - Seeking Alpha” on March 25, 2019. More interesting news about Summit Therapeutics plc (NASDAQ:SMMT) were released by: Seekingalpha.com and their article: “Summit Therapeutics adds to SMT-571-stoked rally, up 18% - Seeking Alpha” published on February 27, 2019 as well as Nasdaq.com‘s news article titled: “Summit Presents In Vivo Proof of Concept Data for New Mechanism Antibiotics Targeting Enterobacteriaceae in Oral Session at ECCMID 2019 - Nasdaq” with publication date: April 14, 2019.

Summit Therapeutics plc, a biopharmaceutical company, focuses on the discovery, development, and commercialization of novel medicines to treat genetic and infectious diseases in the United Kingdom and North America. The company has market cap of $52.65 million. It is conducting clinical programmes focused on the genetic disease Duchenne muscular dystrophy and the infectious disease Clostridium difficile infection (CDI). It has a 1.37 P/E ratio. The companyÂ’s lead DMD product candidate is ezutromid, an orally administered small molecule, which is in Phase II clinical trial in patients with DMD; and lead CDI product candidate is ridinilazole, an orally administered small molecule antibiotic that has completed Phase II clinical trials for the treatment of CDI disease.

More notable recent Advance Auto Parts, Inc. (NYSE:AAP) news were published by: Finance.Yahoo.com which released: “If You Had Bought Advance Auto Parts (NYSE:AAP) Shares A Year Ago You’d Have Made 39% - Yahoo Finance” on May 07, 2019, also Seekingalpha.com with their article: “Consumer Reports: Retail Sales, Sentiment And Earnings - Seeking Alpha” published on May 13, 2019, Streetinsider.com published: “Starboard Value Enters Cerner (CERN), eBay (EBAY), MGM (MGM) (more…) - 13F - StreetInsider.com” on May 15, 2019. More interesting news about Advance Auto Parts, Inc. (NYSE:AAP) were released by: Globenewswire.com and their article: “Update: Lawsuit for Investors in NYSE: AAP shares against Advance Auto Parts, Inc. announced by Shareholders Foundation - GlobeNewswire” published on February 04, 2019 as well as Seekingalpha.com‘s news article titled: “Picking An Auto Part For Safety - Seeking Alpha” with publication date: March 26, 2019.

Analysts await Advance Auto Parts, Inc. (NYSE:AAP) to report earnings on May, 22 before the open. They expect $2.36 EPS, up 12.38% or $0.26 from last year’s $2.1 per share. AAP’s profit will be $169.25 million for 16.73 P/E if the $2.36 EPS becomes a reality. After $1.17 actual EPS reported by Advance Auto Parts, Inc. for the previous quarter, Wall Street now forecasts 101.71% EPS growth.

Among 7 analysts covering Advance Auto Parts (NYSE:AAP), 5 have Buy rating, 0 Sell and 2 Hold. Therefore 71% are positive. Advance Auto Parts had 16 analyst reports since January 7, 2019 according to SRatingsIntel. Jefferies maintained the stock with “Buy” rating in Wednesday, February 20 report. The firm has “Buy” rating given on Tuesday, February 19 by RBC Capital Markets. Bank of America upgraded Advance Auto Parts, Inc. (NYSE:AAP) on Wednesday, January 9 to “Buy” rating. Citigroup maintained the shares of AAP in report on Wednesday, February 20 with “Hold” rating. The stock of Advance Auto Parts, Inc. (NYSE:AAP) has “Buy” rating given on Tuesday, February 19 by Credit Suisse. Barclays Capital upgraded the stock to “Overweight” rating in Monday, January 7 report. The firm has “Neutral” rating by Citigroup given on Monday, April 1. The stock has “Hold” rating by Wells Fargo on Tuesday, February 19. The firm has “Buy” rating given on Wednesday, February 20 by Barclays Capital.

Investors sentiment decreased to 1.18 in 2018 Q4. Its down 0.02, from 1.2 in 2018Q3. It turned negative, as 36 investors sold AAP shares while 144 reduced holdings. 67 funds opened positions while 145 raised stakes. 71.89 million shares or 4.22% more from 68.98 million shares in 2018Q3 were reported. Eagle Asset Management accumulated 16,590 shares. Envestnet Asset Mngmt Incorporated stated it has 0% of its portfolio in Advance Auto Parts, Inc. (NYSE:AAP). Hrt Fincl Ltd Com has 4,172 shares for 0.09% of their portfolio. Manufacturers Life Ins Communication The has 264,464 shares for 0.05% of their portfolio. Point72 Asset Management Limited Partnership invested 0.11% in Advance Auto Parts, Inc. (NYSE:AAP). Parallax Volatility Advisers Limited Partnership accumulated 6,225 shares. M&T National Bank has invested 0% in Advance Auto Parts, Inc. (NYSE:AAP). Segall Bryant & Hamill Ltd Liability Co has invested 0.03% of its portfolio in Advance Auto Parts, Inc. (NYSE:AAP). Gemmer Asset Management Limited Liability Com invested 0.01% of its portfolio in Advance Auto Parts, Inc. (NYSE:AAP). Cookson Peirce Inc, a Pennsylvania-based fund reported 39,815 shares. Yorktown Mngmt & stated it has 5,100 shares or 0.27% of all its holdings. Moreover, Parkside State Bank & Tru has 0.01% invested in Advance Auto Parts, Inc. (NYSE:AAP). Commonwealth Of Pennsylvania Pub School Empls Retrmt holds 0.01% in Advance Auto Parts, Inc. (NYSE:AAP) or 3,977 shares. Rhumbline Advisers invested in 0.05% or 140,603 shares. New York-based Oppenheimer has invested 0.01% in Advance Auto Parts, Inc. (NYSE:AAP).

Moore Capital Management Lp increased Freeport (NYSE:FCX) stake by 100,000 shares to 200,000 valued at $2.06 million in 2018Q4. It also upped Ishares Tr (Put) (EMB) stake by 200,000 shares and now owns 550,000 shares. Marathon Pete Corp (NYSE:MPC) was raised too.

Advance Auto Parts, Inc. (NYSE:AAP) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.